MYLAN SWINGS TO 3Q LOSS ON MEDICAID SETTLEMENT; VIEWS BEAT
October 29, 2009
Mylan Inc. (MYL) swung to a third-quarter loss due to its $121 million settlement of a Medicaid-rebate case, masking higher generic drug revenue.
Related Settlement Stories:
Additional Legal Resources: